Lightnews — Scholar-powered news

Cochrane Hypertension @cochranehtn.bsky.social · 13d

🆕 @cochrane.org Review update 🆕

Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....

In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD

#SystematicReview

Pharmacotherapy for mild hypertension - Wang, D - 2025 | Cochrane Library

Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.

www.cochranelibrary.com

1 3

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 16d

Clearer, more consistent Cochrane reviews are coming.

From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful.

🔗 www.cochrane.org/about-us/new...

1 1

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · Aug 29

Too good to be true? Spotting problematic trials in systematic reviews | Online
🗓️ 26 February
This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial.
🔗 evidencesynthesisireland.ie/conference/w...

Webinar: Dr Jack Wilkinson - Too good to be true? Spotting problematic trials in systematic reviews

To register, CLICK HERE Systematic reviews of randomized controlled trials (RCTs) aim to include all eligible

evidencesynthesisireland.ie

2 2

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · Aug 29

Getting involved in health research reviews: a course for the public | Online
🗓️ 15 September
Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you.
🔗 www.eventbrite.ie/e/getting-in...

Getting Involved in Health Research Reviews: A Course for the Public

Designed for the public and helps you build the knowledge and skills to contribute to research teams conducting health research reviews.

www.eventbrite.ie

1 1 2

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · Aug 29

📣 We're rounding up a few dates for your diary. Discover these events being run by our global network of Cochrane Groups – a thread 🧵

1 2 1

Cochrane Hypertension @cochranehtn.bsky.social · Sep 2

ICYMI - Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot

1

Cochrane Hypertension @cochranehtn.bsky.social · Jun 10

🚨ICYMI - Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing

2 7 7

Reposted by Cochrane Hypertension

deprescribing.org @deprescribing.bsky.social · May 10

Also check out our complementary #deprescribing resources to reduce potentially inappropriate medications found here:
deprescribing.org/resources/de...

Deprescribing Guidelines and Algorithms - Deprescribing.org

deprescribing.org

2 1

Cochrane Hypertension @cochranehtn.bsky.social · May 12

🚨ICYMI - Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing

2 3

Cochrane Hypertension @cochranehtn.bsky.social · Apr 21

🆕 We've published a new Cochrane #SystematicReview protocol:

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...

1 3

Reposted by Cochrane Hypertension

CADeN | ReCAD @caden-recad.bsky.social · Apr 15

SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent.
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

1 4 3

Reposted by Cochrane Hypertension

Therapeutics Initiative @drug-evidence.bsky.social · Apr 14

🚨 ICYMI - TI #BestEvidence webinar:

Dr. Josh Levin compares #PhysicalActivity to drugs for important clinical outcomes
ti.ubc.ca/drugevidence24

#DrugEvidence24 #exercise #MedEd

Dr. Josh Levin: Physical activity compared to drugs for important clinical outcomes.

YouTube video by Therapeutics Initiative

www.youtube.com

5 7

Reposted by Cochrane Hypertension

Therapeutics Initiative @drug-evidence.bsky.social · Apr 15

ICYMI: #BestEvidence webinar recording

Debunking some of the hype in #hypertension
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on #antihypertensives

⏰ chronotherapy
💊 first line tx
🎯 BP targets
⚠️ tx efficacy + safety

#DrugEvidence24 #MedEd #medsafety

Dr. James (Jim) Wright: Debunking some of the hype In hypertension

YouTube video by Therapeutics Initiative

www.youtube.com

4 6

Cochrane Hypertension @cochranehtn.bsky.social · Apr 11

🚨Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing

1 3

Reposted by Cochrane Hypertension

Therapeutics Initiative @drug-evidence.bsky.social · Apr 11

🧵 #ExercisePrescriptions

1/5 The TI’s Dr. Josh Levin asks:
Clinicians, can you help your patients be more active? 🏃🏾‍♀️🏊🏾‍♂️ 🚶🏾‍♂️

👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he...

#Exercise #prescribing #ExerciseRx

Dr. Josh Levin: Exercise prescriptions - Evidence and clinical applications

YouTube video by Therapeutics Initiative

www.youtube.com

1 2 3

Cochrane Hypertension @cochranehtn.bsky.social · Apr 1

🆕 Cochrane #SystematicReview 🆕

Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....

#CochraneEvidence #blogshot #bloodpressure

4 3

Cochrane Hypertension @cochranehtn.bsky.social · Mar 31

🆕 Cochrane #SystematicReview 🆕

Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....

#CochraneEvidence #blogshot #bloodpressure

2 3

Cochrane Hypertension @cochranehtn.bsky.social · Mar 24

ICYMI - Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot

1 3

Cochrane Hypertension @cochranehtn.bsky.social · Mar 12

🚨ICYMI - Cochrane #SystematicReview

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot

3 6

Cochrane Hypertension @cochranehtn.bsky.social · Mar 4

Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2

#CochraneEvidence #Blogshot

5

Cochrane Hypertension @cochranehtn.bsky.social · Mar 4

#BestEvidence webinar recording

Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on #antihypertensives:

⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety

#drugevidence24 #meded #medsafety

Dr. James (Jim) Wright: Debunking some of the hype In hypertension

YouTube video by Therapeutics Initiative

youtu.be

2

Cochrane Hypertension @cochranehtn.bsky.social · Feb 28

🎺 Cochrane #SystematicReview 🚨

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn

#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social

1 5

Cochrane Hypertension @cochranehtn.bsky.social · Feb 27

🎺 Cochrane #SystematicReview 🚨

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot

1 5

Cochrane Hypertension @cochranehtn.bsky.social · Feb 27

🆕 Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence

1 1 3

Cochrane Hypertension @cochranehtn.bsky.social · Feb 24

🆕 #BestEvidence webinar recording

Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on #antihypertensives:

⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety

#drugevidence24 #meded #medsafety

1